Possible influence of the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene on theraputic outcome in affective disorders
- 27 April 2001
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (3) , 258-259
- https://doi.org/10.1038/sj.mp.4000857
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Modulates the Human In Vivo Metabolism of BradykininCirculation, 2000
- Substance-P antagonists: a new treatment for depression?The Lancet, 1998
- Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P ReceptorsScience, 1998
- Author index of volume 277Inorganica Chimica Acta, 1998
- An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disordersBiological Psychiatry, 1996
- Reduction of substance P after chronic antidepressants treatment in the striatum, substantia nigra and amygdala of the ratBrain Research, 1996
- Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in JapanEthnic difference of ACE genotypeAmerican Journal of Hypertension, 1995
- PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)Nucleic Acids Research, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Effects of subchronic treatment with imipramine, zimelidine and alaproclate on regional tissue levels of substance P-and neurokinin a/neurokinin B-like immunoreactivity in the brain and spinal cord of the ratNeuropharmacology, 1987